TGFB1 and neoplasm: However, ILC1s are vulnerable to immunosuppressive signals within the tumor microenvironment (TME), particularly from cytokines like TGF-β and IL-23, which in some cases has been reported to reprogram them into pro-tumoral ILC3-like cells (209).